RE:RE:could it bes1, there is a little restriction called a blackout period preventing insiders from participating in share purchases if material news is imminent, or prior to the release of Quarterly and Annual Financials.
In Medipharms case, insiders loaded up on RSU's, so those options are already as good as safely tucked in the bank account once vesting occurs.
According to SEDI, they are not wasting any time converting those RSUs into common shares
Bring on the spectacular news Mr. Pidduck